Participating in a Trial
At Eastern Connecticut Hematology and Oncology, patients are offered participation in Phase II, Phase III, and Phase IV clinical studies. Other trials offered at ECHO include quality of life and prevention trials that study ways of reducing the risks of getting cancer, particularly in persons at high risk. These trials involve either taking certain medications (such as hormonal medication or vitamins) or modifying their lifestyles (such as smoking cessation).
ECHO Associates is part of a unique quality improvement program, the AIM Higher Initiative, launched in 15 community oncology practices in the U.S. It uses pen-based computer technology designed to facilitate the assessment of symptoms and provide access to scientific and clinical information regarding symptoms.
Research treatments offered by ECHO Associates are reviewed at a number of levels nationally and/ or locally, to ensure both the protection of patients’ rights and the scientific merit of the research. The Institutional Review Board (IRB) is an independent body consisting of medical, scientific, and non-scientific members, whose responsibility is to ensure the protection of each patient’s rights and safety. The IRB assures the well-being of patients involved in every new trial by reviewing, approving, and providing continuing review of trials, protocols, and amendments, and of the methods and materials to be used in obtaining and documenting informed consent of the trial participants. The review process ensures the trial is safe and beneficial to its participants and the medical community.
While some people have very positive results, there are risks and side effects that need to be taken into consideration. Only you, along with your doctor and family, can decide if you should participate. If you are interested in exploring the possibilities of a clinical trial, please make an appointment with one of our oncologists. They will be happy to answer any questions you may have regarding current or upcoming trials and to help determine whether you are a good candidate.
For more information on clinical trials, please contact Dr. Susan Johnson, Director of Research firstname.lastname@example.org or 860-886-8362.